Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VAPB Antikörper (AA 51-150) (Biotin)

VAPB Reaktivität: Ratte WB, ELISA, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal Biotin
Produktnummer ABIN705538
  • Target Alle VAPB Antikörper anzeigen
    VAPB (VAMP (Vesicle-Associated Membrane Protein)-Associated Protein B and C (VAPB))
    Bindungsspezifität
    • 14
    • 8
    • 7
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 51-150
    Reaktivität
    • 44
    • 20
    • 10
    • 1
    • 1
    • 1
    • 1
    • 1
    Ratte
    Wirt
    • 50
    • 7
    • 1
    Kaninchen
    Klonalität
    • 53
    • 5
    Polyklonal
    Konjugat
    • 28
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser VAPB Antikörper ist konjugiert mit Biotin
    Applikation
    • 50
    • 23
    • 13
    • 13
    • 11
    • 7
    • 5
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
    Kreuzreaktivität
    Ratte
    Homologie
    Human,Mouse,Cow,Sheep,Pig,Horse,Chicken,Rabbit
    Aufreinigung
    Purified by Protein A.
    Immunogen
    KLH conjugated synthetic peptide derived from human VAPB
    Isotyp
    IgG
    Top Product
    Discover our top product VAPB Primärantikörper
  • Applikationshinweise
    WB 1:300-5000
    IHC-P 1:200-400
    IHC-F 1:100-500
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Konservierungsmittel
    ProClin
    Vorsichtsmaßnahmen
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store at -20°C for 12 months.
    Haltbarkeit
    12 months
  • Target
    VAPB (VAMP (Vesicle-Associated Membrane Protein)-Associated Protein B and C (VAPB))
    Andere Bezeichnung
    VAPB (VAPB Produkte)
    Synonyme
    ALS8 antikoerper, VAMP-B antikoerper, VAP-B antikoerper, AI225786 antikoerper, AI840687 antikoerper, AI848259 antikoerper, D2Abb2e antikoerper, R75548 antikoerper, VAP33b antikoerper, Vamp33b antikoerper, fc05d09 antikoerper, wu:fa96d05 antikoerper, wu:fc05d09 antikoerper, zgc:66045 antikoerper, vamp-b antikoerper, vamp-c antikoerper, vap-b antikoerper, vap-c antikoerper, vapb antikoerper, VAMP associated protein B and C antikoerper, vesicle-associated membrane protein-associated protein B/C antikoerper, vesicle-associated membrane protein, associated protein B and C antikoerper, VAMP (vesicle-associated membrane protein)-associated protein B and C antikoerper, VAMP (vesicle-associated membrane protein)-associated protein B and C L homeolog antikoerper, VAPB antikoerper, Tsp_07972 antikoerper, Vapb antikoerper, vapb antikoerper, vapb.L antikoerper
    Hintergrund

    Synonyms: ALS 8, ALS8, D2Abb2e, UNQ484/PRO983, Vamp 33b, VAMP associated 33 kDa protein, VAMP associated protein B and C, VAMP associated protein B, VAMP associated protein B/C, VAMP associated protein C, VAMP B, VAMP B VAMP C, VAMP B/VAMP C, VAMP C, VAMP vesicle associated membrane protein associated protein B and C, Vamp33b, VAMPB, VAMPB/VAMPC, VAMPC, VAP 33b, VAP B, VAP B/VAP C, VAP C, VAP33b, VAPB/VAPC, VAPC antibody Vesicle associated membrane protein associated protein B and C, Vesicle associated membrane protein associated protein B/C, VAPB_HUMAN.

    Background: VAPB contains 1 MSP domain and it may play a role in vesicle trafficking. Defects in VAPB are a cause of proximal adult autosomal dominant spinal muscular atrophy [MIM:182980], also called late onset spinal muscular atrophy Finkel type. Spinal muscular atrophies are neurodegenerative disorders characterized by degeneration of lower motor neurons, leading to progressive paralysis muscular atrophy. This form is a late adult onset form of the disease (after age 20 years). The patients show a benign course, most of them remaining ambulatory 10 to 40 years after clinical onset.

    Gen-ID
    9217
    Pathways
    ER-Nucleus Signaling
Sie sind hier:
Kundenservice